Status:
RECRUITING
Assessing Neurocognition After Cerebrovascular Intervention
Lead Sponsor:
University of California, San Diego
Conditions:
Carotid Artery Diseases
Neurocognitive Dysfunction
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
Decreased blood flow to the brain can cause decreased cognitive function. Carotid disease can result in decreased blood flow to the brain. The investigators seek to assess this relationship prospectiv...
Detailed Description
Patients are being asked to partake in this study because the PI has decided on clinical grounds as outlined in the clinical trial, NASCET, (either asymptomatic 70% carotid stenosis or symptomatic \>5...
Eligibility Criteria
Inclusion
- patients \>18 years of age
- ultrasound evidence of carotid stenosis; in which the patient has either 50% or greater symptomatic carotid stenosis or 70% or greater asymptomatic carotid stenosis.
Exclusion
- patients \<18 years of age
- patients with without compatibility for MRI
- patients requiring carotid stenting for reasons not related to long-standing stenosis
- patients requiring emergency carotid stenting for acute symptoms such as crescendo transient ischemic attacks, intolerance of physiologic blood pressure.
- Patients that do not have appropriate capacity (i.e. understand the risks and benefits associated with this study) or are unable to consent for themselves will not be included in this study.
Key Trial Info
Start Date :
July 15 2021
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 1 2025
Estimated Enrollment :
20 Patients enrolled
Trial Details
Trial ID
NCT03344276
Start Date
July 15 2021
End Date
December 1 2025
Last Update
February 6 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
UCSD Medical Center
San Diego, California, United States, 92103